{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:41:50Z","timestamp":1792554110951,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000872","name":"McKnight Endowment Fund for Neuroscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.molmet.2026.102453","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:48:48Z","timestamp":1791319728000},"page":"102453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Parabrachial CGRP neurons mediate incretin-induced aversion and anti-aversion, but not anorexia or weight loss"],"prefix":"10.1016","volume":"114","author":[{"given":"Haley S.","family":"Province","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan A.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7160-9719","authenticated-orcid":false,"given":"Nicholas J.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas W.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5037-693X","authenticated-orcid":false,"given":"Esther","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9489-8098","authenticated-orcid":false,"given":"Lisa R.","family":"Beutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9645","key":"10.1016\/j.molmet.2026.102453_bib1","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.molmet.2026.102453_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.molmet.2026.102453_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.molmet.2026.102453_bib4","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/dci24-0003","article-title":"Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity","volume":"47","author":"Drucker","year":"2024","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.molmet.2026.102453_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.molmet.2026.102453_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13929","article-title":"Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: a systematic review and meta-analysis","volume":"26","author":"Berg","year":"2025","journal-title":"Obes Rev"},{"key":"10.1016\/j.molmet.2026.102453_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103680","article-title":"Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis","volume":"90","author":"Tzang","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.molmet.2026.102453_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Frias","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.molmet.2026.102453_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.molmet.2026.102453_bib10","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamainternmed.2024.2525","article-title":"Semaglutide vs tirzepatide for weight loss in adults with overweight or obesity","volume":"184","author":"Rodriguez","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.molmet.2026.102453_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metabol"},{"issue":"10160","key":"10.1016\/j.molmet.2026.102453_bib12","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.molmet.2026.102453_bib13","doi-asserted-by":"crossref","first-page":"E528","DOI":"10.1152\/ajpendo.00330.2023","article-title":"The antiemetic actions of GIP receptor agonism","volume":"326","author":"Borner","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.molmet.2026.102453_bib14","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/dbi21-0002","article-title":"GIPR function in the central nervous system: implications and novel perspectives for GIP-based therapies in treating metabolic disorders","volume":"70","author":"Samms","year":"2021","journal-title":"Diabetes"},{"issue":"25","key":"10.1016\/j.molmet.2026.102453_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu1589","article-title":"Hypophagia and body weight loss by tirzepatide are accompanied by fewer GI adverse events compared to semaglutide in preclinical models","volume":"11","author":"Borner","year":"2025","journal-title":"Sci Adv"},{"issue":"11","key":"10.1016\/j.molmet.2026.102453_bib16","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2337\/db21-0459","article-title":"GIP receptor agonism attenuates GLP-1 receptor agonist-induced nausea and emesis in preclinical models","volume":"70","author":"Borner","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2026.102453_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101743","article-title":"GIP receptor agonism blocks chemotherapy-induced nausea and vomiting","volume":"73","author":"Borner","year":"2023","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2026.102453_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101407","article-title":"Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation","volume":"55","author":"Costa","year":"2022","journal-title":"Mol Metabol"},{"issue":"4","key":"10.1016\/j.molmet.2026.102453_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2026.117116","article-title":"GIP receptor agonism suppresses inflammation-induced aversion and food intake via distinct circuits","volume":"45","author":"Province","year":"2026","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.molmet.2026.102453_bib20","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2337\/db21-0848","article-title":"GIPR agonism inhibits PYY-induced nausea-like behavior","volume":"71","author":"Samms","year":"2022","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.molmet.2026.102453_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110953","article-title":"A brainstem circuit for nausea suppression","volume":"39","author":"Zhang","year":"2022","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/j.molmet.2026.102453_bib22","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1111\/dom.15875","article-title":"A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy","volume":"26","author":"Knop","year":"2024","journal-title":"Diabetes Obes Metabol"},{"issue":"8025","key":"10.1016\/j.molmet.2026.102453_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-024-07685-6","article-title":"Dissociable hindbrain GLP1R circuits for satiety and aversion","volume":"632","author":"Huang","year":"2024","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.molmet.2026.102453_bib24","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/s42255-023-00931-7","article-title":"Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice","volume":"5","author":"Liskiewicz","year":"2023","journal-title":"Nat Metab"},{"issue":"6","key":"10.1016\/j.molmet.2026.102453_bib25","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1172\/JCI72434","article-title":"Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect","volume":"124","author":"Sisley","year":"2014","journal-title":"J Clin Investig"},{"key":"10.1016\/j.molmet.2026.102453_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102074","article-title":"Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss","volume":"95","author":"Wean","year":"2025","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2026.102453_bib27","series-title":"A single dorsal vagal complex circuit mediates the aversive and anorectic responses to GLP1R agonists","author":"Yacawych","year":"2025"},{"issue":"4","key":"10.1016\/j.molmet.2026.102453_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmet.2021.01.015","article-title":"The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.molmet.2026.102453_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164921","article-title":"Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding","volume":"8","author":"Adriaenssens","year":"2023","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.molmet.2026.102453_bib30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmet.2019.07.013","article-title":"Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake","volume":"30","author":"Adriaenssens","year":"2019","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.molmet.2026.102453_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J Comp Neurol"},{"issue":"2","key":"10.1016\/j.molmet.2026.102453_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cmet.2019.12.012","article-title":"Calcitonin receptor neurons in the mouse nucleus tractus solitarius control energy balance via the non-aversive suppression of feeding","volume":"31","author":"Cheng","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.molmet.2026.102453_bib33","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1038\/s41467-021-25525-3","article-title":"NTS prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity","volume":"12","author":"Cheng","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2026.102453_bib34","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuroscience.2017.06.049","article-title":"A tale of two circuits: CCK(NTS) neuron stimulation controls appetite and induces opposing motivational states by projections to distinct brain regions","volume":"358","author":"Roman","year":"2017","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.molmet.2026.102453_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cmet.2016.04.006","article-title":"Parabrachial CGRP neurons control meal termination","volume":"23","author":"Campos","year":"2016","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.molmet.2026.102453_bib36","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/s42255-026-01575-z","article-title":"Distinct brain regions mediate regulation of food intake in response to GIPR agonism or antagonism","volume":"8","author":"Lewis","year":"2026","journal-title":"Nat Metab"},{"issue":"7474","key":"10.1016\/j.molmet.2026.102453_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature12596","article-title":"Genetic identification of a neural circuit that suppresses appetite","volume":"503","author":"Carter","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.molmet.2026.102453_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021357118","article-title":"GFRAL-Expressing neurons suppress food intake via aversive pathways","volume":"118","author":"Sabatini","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2026.102453_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102138","article-title":"A key role for parabrachial nucleus CGRP neurons in FGF1-Induced anorexia","volume":"96","author":"Scarlett","year":"2025","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2026.102453_bib40","series-title":"Ingestion-activated CGRP neurons control learning but not satiety","author":"Jarvie","year":"2025"},{"issue":"7698","key":"10.1016\/j.molmet.2026.102453_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nature25511","article-title":"Encoding of danger by parabrachial CGRP neurons","volume":"555","author":"Campos","year":"2018","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.molmet.2026.102453_bib42","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1523\/JNEUROSCI.3729-14.2015","article-title":"Parabrachial calcitonin gene-related peptide neurons mediate conditioned taste aversion","volume":"35","author":"Carter","year":"2015","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.molmet.2026.102453_bib43","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neuron.2018.09.032","article-title":"Parabrachial CGRP neurons establish and sustain aversive taste memories","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.molmet.2026.102453_bib44","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/nn.4574","article-title":"Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus","volume":"20","author":"Campos","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.molmet.2026.102453_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101523","article-title":"Parabrachial CGRP neurons modulate active defensive behavior under a naturalistic threat","volume":"14","author":"Pyeon","year":"2025","journal-title":"eLife"},{"issue":"10","key":"10.1016\/j.molmet.2026.102453_bib46","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41366-022-01174-4","article-title":"Sex-specific changes in metabolism during the transition from chow to high-fat diet feeding are abolished in response to dieting in C57BL\/6J mice","volume":"46","author":"Oraha","year":"2022","journal-title":"Int J Obes"},{"issue":"9","key":"10.1016\/j.molmet.2026.102453_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046057","article-title":"Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue","volume":"7","author":"Pettersson","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.molmet.2026.102453_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13293-023-00580-1","article-title":"Sex differences in a mouse model of diet-induced obesity: the role of the gut microbiome","volume":"15","author":"Stapleton","year":"2024","journal-title":"Biol Sex Differ"},{"issue":"21","key":"10.1016\/j.molmet.2026.102453_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186652","article-title":"Incretin receptor agonism rapidly inhibits AgRP neurons to suppress food intake in mice","volume":"135","author":"McMorrow","year":"2025","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.molmet.2026.102453_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2017.06.031","article-title":"Central administration of GLP-1 and GIP decreases feeding in mice","volume":"490","author":"NamKoong","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.molmet.2026.102453_bib51","first-page":"361","article-title":"BRL 43694, a new 5HT3 receptor antagonist, prevents cisplatin-induced emesis in dogs","volume":"11","author":"Bhandari","year":"1989","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.molmet.2026.102453_bib52","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0750-7658(05)80754-3","article-title":"[prevention of postoperative nausea and vomiting by ondansetron]","volume":"11","author":"Bouly","year":"1992","journal-title":"Ann Fr Anesth Reanim"},{"issue":"12","key":"10.1016\/j.molmet.2026.102453_bib53","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM199003223221204","article-title":"Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting","volume":"322","author":"Cubeddu","year":"1990","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.molmet.2026.102453_bib54","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1464-5491.2010.03085.x","article-title":"Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects","volume":"27","author":"Ellero","year":"2010","journal-title":"Diabet Med"},{"issue":"3\u20134","key":"10.1016\/j.molmet.2026.102453_bib55","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0305-7372(87)90026-0","article-title":"Antiemetic properties of the 5HT3-receptor antagonist, GR38032F","volume":"14","author":"Stables","year":"1987","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"10.1016\/j.molmet.2026.102453_bib56","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s42255-026-01534-8","article-title":"Semaglutide drives weight loss through cAMP-dependent mechanisms in GLP1R-expressing hindbrain neurons","volume":"8","author":"Gao","year":"2026","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2026.102453_bib57","series-title":"Gip receptor activating peptide","author":"Taiji Asami","year":"2017"},{"key":"10.1016\/j.molmet.2026.102453_bib58","series-title":"A study to evaluate LY3537021 for the treatment of nausea and vomiting caused by chemotherapy in adults with cancer","author":"Lilly","year":"2026"},{"key":"10.1016\/j.molmet.2026.102453_bib59","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81868","article-title":"Molecular and anatomical characterization of parabrachial neurons and their axonal projections","volume":"11","author":"Pauli","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.molmet.2026.102453_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101240","article-title":"A survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing","volume":"53","author":"Dowsett","year":"2021","journal-title":"Mol Metabol"},{"issue":"9","key":"10.1016\/j.molmet.2026.102453_bib61","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.cmet.2025.07.009","article-title":"Glucose-dependent insulinotropic polypeptide receptor signaling in oligodendrocytes increases the weight-loss action of GLP-1R agonism","volume":"37","author":"Hansford","year":"2025","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.molmet.2026.102453_bib62","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2337\/dbi21-0003","article-title":"Single-cell mapping of GLP-1 and GIP receptor expression in the dorsal vagal complex","volume":"70","author":"Ludwig","year":"2021","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.molmet.2026.102453_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jdi.12129","article-title":"Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice","volume":"5","author":"Okawa","year":"2014","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.molmet.2026.102453_bib64","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molmet.2018.03.004","article-title":"Enterochromaffin 5-HT cells \u2013 a major target for GLP-1 and gut microbial metabolites","volume":"11","author":"Lund","year":"2018","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2026.102453_bib65","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/annonc\/4.suppl_3.S9","article-title":"Review of experience with ondansetron and granisetron","volume":"4","author":"Aapro","year":"1993","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.molmet.2026.102453_bib66","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/obr.12663","article-title":"Home alone: a systematic review and meta-analysis on the effects of individual housing on body weight, food intake and visceral fat mass in rodents","volume":"19","author":"Schipper","year":"2018","journal-title":"Obes Rev"},{"issue":"9861","key":"10.1016\/j.molmet.2026.102453_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(12)61267-7","article-title":"Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study","volume":"381","author":"Buse","year":"2013","journal-title":"Lancet"},{"issue":"8068","key":"10.1016\/j.molmet.2026.102453_bib68","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-025-08828-z","article-title":"A neural mechanism for learning from delayed postingestive feedback","volume":"642","author":"Zimmerman","year":"2025","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molmet.2026.102453_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113675","article-title":"Sucrose overconsumption impairs AgRP neuron dynamics and promotes palatable food intake","volume":"43","author":"Lorch","year":"2024","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.molmet.2026.102453_bib70","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1038\/s41467-020-19767-w","article-title":"Parabrachial nucleus circuit governs neuropathic pain-like behavior","volume":"11","author":"Sun","year":"2020","journal-title":"Nat Commun"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:14:44Z","timestamp":1792552484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877826001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":70,"alternative-id":["S2212877826001377"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102453","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parabrachial CGRP neurons mediate incretin-induced aversion and anti-aversion, but not anorexia or weight loss","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102453"}}